G. PIERRI, M. VIOLA - Vol. 10, March 2004, Issue 1
Testo Immagini Bibliografia Summary Indice
1 Katzung B. G. Farmacologia Generale e Clinica;Piccin 1997 Padova: 494-511
2 Ishiwata K, Kobayashi T, Kawamura K, Matsuno K, Senda M. [11C]Raclopride binding was reduced in vivo by sigma(1) receptor ligand SA4503 in the mouse brain, while [11C]SA4503 binding was not by raclopride: Nuclear Medicine Biology 2001 OCT;28(7):787-92.
3 Minabe Y, Matsuno K, Ashby CR Jr; Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats:An in vivo electrophysiological study:Synapse 1999 Aug;33(2):129-40.
4 Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman A;Le basi farmacologiche della terapia;ed. MacGraw Hill Milano:519-539.
5 Kawamura K, Ishiwata K, Shimada Y, Kimura Y, Kobayashi T, Mat K, Homma Y, Senda M. Preclinical evalutation of [11C]SA4503:radiation dosimetry, in vivo selectivity and PET imaging of sigma1 receptors in the cat brain.:Ann. Nucl. Med 2000 Aug;14(4):285-92.
6 Zhang MR, Haradahira T, Maeda J, Okauchi T, Kawabe K, Kida T, Obayashi S, Suzuki K, Suhara T. Nucl. Med. Biol. 2002 May; 29(4):469-76. Synthesis and evaluation of 3-(4-chlorbenzyl [11c]methoxy-1, 2, 3, 4- Tetrahydrochomeno[3, 4-c]pyridin-5-one: a PET tracer for imaging sigma(1) receptors.
7 Skuza G. Combined treatment with NMDA antagonist, CGP 37849, and sigma receptor agonists, SA4503 or DTG, decreases the neuroleptic-induced catalepsy in rats: Pol. J. Pharmacology 2000 Jul-Aug;52(4):313-6.
8 Ukai M, Maeda H, Nanya Y, Kameyama T, Matsuno K. Beneficial effects of acute and repeated admnistration receptor agonists on behavioural despair in mice expect suspension. Pharmacol Biochem Behav 1998;61:247-52.
9 Zou LB, Yamada K, Nabeshima T. Sigma receptor ligands(+)-SKF 10, 047 and SA 4503 improve dizocilpine-induced spatial memory deficts in rats. Eur J Pharmacol 1998;355:1-10.
10 Noda A, Noda Y, Kamei H, Ichihara K, Mamiya T, Nagai T, et al. Phencyclidine impairs latent learning in mice: interaction between glutamatergic systems and sigma1 receptors. Neuropsychopharmacology 2001;24:451-60.
11 Yamazaki Y, Ishioka M, Matsubayashi H, Amano T, Sasa M. Inhibition by sigma receptor ligand, MS-377, of N-methyl-D-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area. Psychopharmacology (Berl) 2002;161:64-9.
12 Karasawa J, Takahashi S, Takagi K, Horikomi K. Effects of sigma1 receptor ligand MS-377 of D(2) antagonists-induced behaviors. Pharmacol Biochem Behav 2002;73:505-10
13 Kawamura K, Ishiwata K, Tajima H, Ishii S, Shimada Y, Matsuno K, et al. Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand. Nucl Med Biol 1999;26:915-22
14 Skuza G, Kolasiewicz W. Repeated treatment with SA4503, a selective sigma1 receptor agonist, up-regulates alpha-adrenergic system. A behavioural study.Pol J Pharmacol 2001;53.
15 Karasawa J, Yamamoto H, Yamamoto T, Sagi N, Horikomi K, Sora I. MS-377, a selective sigma receptor ligand, indirectly blocks the action of PCP in the N-methyl-D-aspartate receptor ion-channel complex in primary cultured rat neuronal cel. Life Sci 2002;70:1631-42